Hypoxia favors the generation of human plasma cells

References

• O'Connor BP, Gleeson MW, Noelle RJ, Erickson LD. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunol Rev 2003; 194:61-76; PMID:12846808; https://doi.org/10.1034/j.1600-065X.2003.00055.x
   PubMed Web of Science ®Google Scholar
• Tangye SG. Staying alive: regulation of plasma cell survival. Trends Immunol 2011; 32:595-602; PMID:22001488; https://doi.org/10.1016/j.it.2011.09.001
   PubMed Web of Science ®Google Scholar
• Jourdan M, Caraux A, De Vos J, Fiol G, Larroque M, Cognot C, Bret C, Duperray C, Hose D, Klein B. An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization. Blood 2009; 114:5173-81; PMID:19846886; https://doi.org/10.1182/blood-2009-07-235960
   PubMed Web of Science ®Google Scholar
• Mei HE, Yoshida T, Sime W, Hiepe F, Thiele K, Manz RA, Radbruch A, Dorner T. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 2009; 113:2461-9; PMID:18987362; https://doi.org/10.1182/blood-2008-04-153544
   PubMed Web of Science ®Google Scholar
• Cocco M, Stephenson S, Care MA, Newton D, Barnes NA, Davison A, Rawstron A, Westhead DR, Doody GM, Tooze RM. In vitro generation of long-lived human plasma cells. J Immunol 2012; 189:5773-85; PMID:23162129; https://doi.org/10.4049/jimmunol.1103720
   PubMed Web of Science ®Google Scholar
• Jourdan M, Cren M, Robert N, Bollore K, Fest T, Duperray C, Guilloton F, Hose D, Tarte K, Klein B. IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors. Leukemia 2014; 28(8):1647-56; PMID:24504026; https://doi.org/10.1038/leu.2014.61
   PubMed Web of Science ®Google Scholar
• Chow DC, Wenning LA, Miller WM, Papoutsakis ET. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J 2001; 81:685-96; PMID:11463617; https://doi.org/10.1016/S0006-3495(01)75733-5
   PubMed Web of Science ®Google Scholar
• Tsai AG, Friesenecker B, Mazzoni MC, Kerger H, Buerk DG, Johnson PC, Intaglietta M. Microvascular and tissue oxygen gradients in the rat mesentery. Proc Natl Acad Sci U S A 1998; 95:6590-5; PMID:9618456; https://doi.org/10.1073/pnas.95.12.6590
   PubMed Web of Science ®Google Scholar
• Abbott RK, Thayer M, Labuda J, Silva M, Philbrook P, Cain DW, Kojima H, Hatfield S, Sethumadhavan S, Ohta A, et al. Germinal Center Hypoxia Potentiates Immunoglobulin Class Switch Recombination. J Immunol 2016; 197:4014-20; PMID:27798169; https://doi.org/10.4049/jimmunol.1601401
   PubMed Web of Science ®Google Scholar
• Ricciardi A, Elia AR, Cappello P, Puppo M, Vanni C, Fardin P, Eva A, Munroe D, Wu X, Giovarelli M, et al. Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol Cancer Res 2008; 6:175-85; PMID:18314479; https://doi.org/10.1158/1541-7786.MCR-07-0391
   PubMed Web of Science ®Google Scholar
• Jourdan M, Caraux A, Caron G, Robert N, Fiol G, Reme T, Bollore K, Vendrell JP, Le Gallou S, Mourcin F, et al. Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation. J Immunol 2011; 187:3931-41; PMID:21918187; https://doi.org/10.4049/jimmunol.1101230
   PubMed Web of Science ®Google Scholar
• Schoenhals M, Jourdan M, Seckinger A, Pantesco V, Hose D, Kassambara A, Moreaux J, Klein B. Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage. Cell Cycle 2016; 15(14):1919-28: 0; PMID:27230497; https://doi.org/10.1080/15384101.2016.1191709
   PubMed Web of Science ®Google Scholar
• Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003; 23:9361-74; PMID:14645546; https://doi.org/10.1128/MCB.23.24.9361-9374.2003
   PubMed Web of Science ®Google Scholar
• Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721-32; PMID:13130303; https://doi.org/10.1038/nrc1187
   PubMed Web of Science ®Google Scholar
• Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007; 11:335-47; PMID:17418410; https://doi.org/10.1016/j.ccr.2007.02.006
   PubMed Web of Science ®Google Scholar
• Giatromanolaki A, Bai M, Margaritis D, Bourantas KL, Koukourakis MI, Sivridis E, Gatter KC. Hypoxia and activated VEGF/receptor pathway in multiple myeloma. Anticancer Res 2010; 30:2831-6; PMID:20683019
   PubMed Web of Science ®Google Scholar
• Martin SK, Diamond P, Williams SA, To LB, Peet DJ, Fujii N, Gronthos S, Harris AL, Zannettino AC. Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells. Haematologica 2010; 95:776-84; PMID:20015878; https://doi.org/10.3324/haematol.2009.015628
   PubMed Web of Science ®Google Scholar
• Dean M, Kent RB, Sonenshein GE. Transcriptional activation of immunoglobulin alpha heavy-chain genes by translocation of the c-myc oncogene. Nature 1983; 305:443-6; PMID:6413865; https://doi.org/10.1038/305443a0
   PubMed Web of Science ®Google Scholar
• Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W, Powell J, Dave S, Yu X, Zhao H, et al. IRF4 addiction in multiple myeloma. Nature 2008; 454:226-31; PMID:18568025; https://doi.org/10.1038/nature07064
   PubMed Web of Science ®Google Scholar
• Eales KL, Hollinshead KE, Tennant DA. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis 2016; 5:e190; PMID:26807645; https://doi.org/10.1038/oncsis.2015.50
   PubMed Web of Science ®Google Scholar
• Maiso P, Huynh D, Moschetta M, Sacco A, Aljawai Y, Mishima Y, Asara JM, Roccaro AM, Kimmelman AC, Ghobrial IM. Metabolic signature identifies novel targets for drug resistance in multiple myeloma. Cancer Res 2015; 75:2071-82; PMID:25769724; https://doi.org/10.1158/0008-5472.CAN-14-3400
   PubMed Web of Science ®Google Scholar
• D'Souza S, Kurihara N, Shiozawa Y, Joseph J, Taichman R, Galson DL, Roodman GD. Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment. Blood 2012; 119:1888-96; PMID:22223826; https://doi.org/10.1182/blood-2011-11-393348
   PubMed Web of Science ®Google Scholar
• Sharma MC, Sharma M. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharmaceutical Design 2007; 13:3568-75; PMID:18220793; https://doi.org/10.2174/138161207782794167
   PubMed Web of Science ®Google Scholar
• Menaa C, Devlin RD, Reddy SV, Gazitt Y, Choi SJ, Roodman GD. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Clin Invest 1999; 103:1605-13; PMID:10359570; https://doi.org/10.1172/JCI6374
   PubMed Web of Science ®Google Scholar
• Li F, Chung H, Reddy SV, Lu G, Kurihara N, Zhao AZ, Roodman GD. Annexin II stimulates RANKL expression through MAPK. J Bone Miner Res 2005; 20:1161-7; PMID:15940368; https://doi.org/10.1359/JBMR.050207
   PubMed Web of Science ®Google Scholar
• Seckinger A, Meissner T, Moreaux J, Depeweg D, Hillengass J, Hose K, Reme T, Rosen-Wolff A, Jauch A, Schnettler R, et al. Clinical and prognostic role of annexin A2 in multiple myeloma. Blood 2012; 120:1087-94; PMID:22705595; https://doi.org/10.1182/blood-2012-03-415588
   PubMed Web of Science ®Google Scholar
• Burg JM, Link JE, Morgan BS, Heller FJ, Hargrove AE, McCafferty DG. KDM1 class flavin-dependent protein lysine demethylases. Biopolymers 2015; 104:213-46; PMID:25787087; https://doi.org/10.1002/bip.22643
   PubMed Web of Science ®Google Scholar
• Fang R, Barbera AJ, Xu Y, Rutenberg M, Leonor T, Bi Q, Lan F, Mei P, Yuan GC, Lian C, et al. Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation. Mol Cell 2010; 39:222-33; PMID:20670891; https://doi.org/10.1016/j.molcel.2010.07.008
   PubMed Web of Science ®Google Scholar
• van Essen D, Zhu Y, Saccani S. A feed-forward circuit controlling inducible NF-kappaB target gene activation by promoter histone demethylation. Mol Cell 2010; 39:750-60; PMID:20832726; https://doi.org/10.1016/j.molcel.2010.08.010
   PubMed Web of Science ®Google Scholar
• Demchenko YN, Kuehl WM. A critical role for the NFkB pathway in multiple myeloma. Oncotarget 2010; 1:59-68; PMID:20890394; https://doi.org/10.18632/oncotarget.109
   PubMed Web of Science ®Google Scholar
• Demchenko YN, Glebov OK, Zingone A, Keats JJ, Bergsagel PL, Kuehl WM. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma. Blood 2010; 115:3541-52; PMID:20053756; https://doi.org/10.1182/blood-2009-09-243535
   PubMed Web of Science ®Google Scholar
• Kassambara A, Reme T, Jourdan M, Fest T, Hose D, Tarte K, Klein B. GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells. PLoS Comput Biol 2015; 11:e1004077; PMID:25633866; https://doi.org/10.1371/journal.pcbi.1004077
   PubMed Web of Science ®Google Scholar
• Feichtinger J, Thallinger G, McFarlane R, Larcombe L. Microarray meta-analysis: From data to expression to biological relationships. In: Trajanoski Z, editor, Computational Medicine. Vienna, Austria: Springer; 2012; 59-77.
   Google Scholar